This service is more advanced with JavaScript available, learn more at http://activatejavascript.org

Reactions Weekly

April 2018, Volume 1697, Issue 1, pp 43–43 | Cite as

Anti-ctla-4-monoclonal antibody

Severe immune related colitis: case report

Case report

First Online: 14 April 2018

11 Downloads

This is a preview of subscription content, to check access

Reference

Subrahmanyam PB, et al. Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients. Journal for ImmunoTherapy of Cancer 6: No. 1, 6 Mar 2018. Available from: URL: http://doi.org/10.1186/s40425-018-0328-8 - USA

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

About this article

Cite this article as:: Reactions Weekly (2018) 1697: 43. https://doi.org/10.1007/s40278-018-44599-y

DOI https://doi.org/10.1007/s40278-018-44599-y
Publisher Name Springer International Publishing
Print ISSN 0114-9954
Online ISSN 1179-2051

Published in cooperation with
Adis

Personalised recommendations